Allergic reactions to cyclophosphamide: Delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 1 I, 1996, Pages 26-33

  Popescu, N Andrei ^a,b   Sheehan, Michael G ^a   Kouides, Peter A ^a   Loughner, John E ^a   Condemi, John J ^a   Looney, Richard J ^a   Leddy, John P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNITY HEALTH SYSTEM   (United States)

Author keywords

allergy to drug metabolites; anaphylaxis; cyclophosphamide; Drug allergy; IgE antibody

Indexed keywords

CYCLOPHOSPHAMIDE; DRUG METABOLITE; IMMUNOGLOBULIN E;

ADULT; ALLERGIC REACTION; ALLERGY; ANAPHYLAXIS; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; PRICK TEST; PRIORITY JOURNAL;

EID: 0030049602     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70279-8     Document Type: Article

References (32)

1. Lakin JD, Cahill RA. Generalized urticaria to cyclophosphamide: type I hypersensitivity to an immunosuppressive agent. J ALLERGY CLIN IMMUNOL 1975;58:160-71.
2. Karchmer RK, Hansen VL. Possible anaphylactic reaction to intravenous cyclophosphamide. JAMA 1977;237:475-6.
3. Ross WE, Chabner BA. Allergic reaction to cyclophosphamide in a mechlorethamine-sensitive patient. Cancer Treatment Reports 1977;61:495-6.
4. Krutchik AN, Buzdar AU, Tashima CK. Cyclophos-phamide-induced urticaria. Occurrence in a patient with no cross-sensitivity to chlorambucil. Arch Intern Med 1978; 138:1725-6.
5. Legha SS, Hall S. Acute cyclophosphamide hypersensitivity reaction: Possible lack of cross-sensitivity to mechloreth-amine and ispphosphamide. Cancer Treatment Reports 1978;62:180-1.
6. Murti L, Horsman LR. Acute hypersensitivity reaction to cyclophosphamide. J Pediatrics 1979;94:844-5.
7. Anku V. Apparent cyclophosphamide hypersensitivity: Urticaria associated with cyclophosphamide without prior sensitization. Cancer Treatment Reports 1982;66:2106-7.
8. Aulbert E, Schmidt CG. Anaphylaktische reaktion unter cyclophosphamid-infusion. Onkologie 1983;6:82-3.
9. Kim HC, Kesarwala HH, Colvin M, Saidi P. Hypersensitivity reaction to a metabolite of cyclophosphamide. J ALLERGY CLIN IMMUNOL 1985;76:591-4.
10. Kath R, Hoffken K, Schmidt CG. Idiosynkratische reaktion unter cyclophosphamid-infusion. Deutsche Medizinesche Wochenschrift 1986;11:1622.
11. Kritharides L, Lawrie K, Varigos GA. Cyclophosphamide hypersensitivity and cross-reactivity with chlorambucil. Cancer Treatment Reports 1987;71:1323-4.
12. Grosbois B, Bedossa M, Hoel JC, Genetet N, Leblay R. Reaction urtricarienne apres administration intraveineuse de cyclophosphamide chez deux patients atteints d'un myelome multiple. Rev Med Interne 1987;8:208-9.
13. Green RM, Schapel GJ, Sage RE. Cutaneous vasculitis due to cyclophosphamide therapy for chronic lymphocytic leukemia. Aust NZ J Med 1989;19:55-7.
14. Jones JB, Purdy CY, Bailey RT Jr. Cyclophosphamide anaphylaxis. DICP, Annals Pharmacol 1989;23:88-9.
15. Salles G, Vial T. Archimbaud E. Anaphylactoid reaction with bronchospasm following intravenous cyclophosphamide administration. Ann Hematol 1991;62:74-5.
16. Cromar BW, Colvin M, Casale TB. Validity of skin tests to cyclophosphamide and metabolites. J ALLERGY CLIN IMMUNOL 1991;88:965-7.
17. Knysak DJ, McLean JA, Solomon WR, Fox DA, McClune WJ. Immediate hypersensitivity reaction to cyclophosphamide. Arthritis Rheum 1994;37:1101-4.
18. Low JE, Borch RF, Sladek NE. Conversion of 4-hydroper-oxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysts. Cancer Research 1982;42:830-7.
19. Borch RF, Millard JA. The mechanism of activation of 4-hydroxycyclophosphamide. J Med Chem 1987;30:427-31.
20. Kelly JW, Dooley DP, Lattuada CP, Smith CE. A severe, unusual reaction to trimethaprim-sulfamethoxazole in patients infected with human immunodeficiency virus. Clin Infect Dis 1992;14:1034-9.
21. Sladek NE. Oxazophosphorines. In: Povis G, Prough RA, eds. Metabolism and action of anti-cancer drugs, New York: Taylor and Francis, 1987:48-90.
22. Moore MJ. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 1991;20:194-208.
23. Tasso MJ, Boddy AV, Price L, Wyllie RA, Pearson ADJ, Idle JR. Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients. Cancer Chemother Pharmacol 1992;30:207-11.
24. Sullivan TJ. Drug allergy. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy, principles and practice. 4th ed. St Louis: Mosby-Year Book, 1993:1726-46.
25. Lemanske RF Jr, Kaliner MA. Late-phase allergic reactions. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy, principles and practice. 4th ed. St Louis: Mosby-Year Book, 1993:320-61.
26. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J ALLERGY CLIN IMMUNOL 1986;78:76-83.
27. Delage C, Mullick FG, Irey NS. Myocardial lesions in anaphylaxis. Arch Pathol Lab Med 1973;95:185-9.
28. Booth PH, Patterson R. Electrocardiographic changes during human anaphylaxis. JAMA 1970;211:627-30.
29. James LP Jr, Austen KF. Fatal systemic anaphylaxis in man. N Engl J Med 1964;270:597-603.
30. Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H, Valentine MD, Permutt S, Lichtenstein LM. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980;66:1072-80.
31. Sheffer AL. Anaphylaxis. J ALLERGY CLIN IMMUNOL 1985; 75:227-33.
32. Tannenbaum H, Ruddy S, Schur PH. Acute anaphylaxis associated with serum complement depletion. J ALLERGY CLIN IMMUNOL 1975;56:276-81.